Maso, L., Mosure, S. A., Rodriguez-Aponte, S. A., Pizzo, A., Mensah, D. N., Southard, M., Sze, S., Ahmed, T., Vash, B., Hattori, T., Rajak, E., Koide, A., Neel, B. G., Koide, S., Liu, W., Toenjes, S. T., Jardine, P. D. S., Chopra, R., Rader, C., Stopfer, L. E. (2025). Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy. Nature Communications. https://doi.org/10.1038/s41467-025-66132-w